Rosskopf Sandra, Gyurján István, Soldo Regina, Luna-Coronell Johana A, Vierlinger Klemens, Singer Christian F, Rappaport Christine, Pecha Nina, Weinhaeusel Andreas
Austrian Institute of Technology AIT, Health & Environment - Molecular Diagnostics, Vienna, Austria.
Austrian Institute of Technology AIT, Health & Environment - Molecular Diagnostics, Vienna, Austria.
J Immunol Methods. 2015 Mar;418:39-51. doi: 10.1016/j.jim.2015.01.009. Epub 2015 Feb 9.
Specimen collection method and quality insurance are pivotal in biomarker discovery. Pre-analytical variables concerning blood collection and sample handling might affect analytical results and should be standardised prior application. In this study, we examine pre-analytical characteristics of blood samples using protein microarray. The influences of 1) standby times until centrifugation (1 h, 4 h, 24 h and 48 h), 2) four blood collection methods, and 3) IgG purified from those samples on differentially reactive antigens between samples ("DIRAGs") were investigated. Spearman correlation analyses of intra-individual arrays demonstrated remarkable differences (0.75-0.98 vs. 0.5-0.75) of antibody reactivities within and between serum and plasma samples. Class comparison showed that reactive antigen profiles were best preserved using IgG purified samples of serum tubes without separation gel as after 24h 83% of the 1h baseline DIRAGs were re-found. Testing dilution series with protein microarrays and Luminex xMap® Technology, we found linear correlations (R(2) = 0.94-0.99) between IgG concentration and read-out when using purified IgG instead of serum. Therefore, we highly recommend standardising pre-analytics and proposing the use of purified IgG for autoantibody immune-profiling with protein microarrays to reduce potential unspecific binding of matrix proteins abundant in serum and plasma samples.
Although purified IgG cannot completely compensate the influence of pre-analytics, in highly parallel immune-profiling IgG enables reduction of unspecific effects, which occur when using serum or plasma for analysis on protein microarrays. Reproducibility problems due to pre-analytical processing of blood samples might explain discrepant results reported in various biomarker studies.
样本采集方法和质量保证在生物标志物发现中至关重要。与血液采集和样本处理相关的分析前变量可能会影响分析结果,在应用前应进行标准化。在本研究中,我们使用蛋白质微阵列检测血液样本的分析前特征。研究了1)离心前的静置时间(1小时、4小时、24小时和48小时)、2)四种血液采集方法以及3)从这些样本中纯化的IgG对样本间差异反应性抗原(“DIRAGs”)的影响。个体内阵列的Spearman相关性分析表明,血清和血浆样本内部以及之间的抗体反应性存在显著差异(0.75 - 0.98对0.5 - 0.75)。类别比较显示,使用未加分离胶的血清管纯化的IgG样本时,反应性抗原谱保存得最好,因为在24小时后,重新发现了1小时基线DIRAGs中的83%。通过蛋白质微阵列和Luminex xMap®技术检测稀释系列,我们发现使用纯化的IgG而非血清时,IgG浓度与读数之间存在线性相关性(R² = 0.94 - 0.99)。因此,我们强烈建议对分析前因素进行标准化,并建议使用纯化的IgG进行蛋白质微阵列自身抗体免疫分析,以减少血清和血浆样本中丰富的基质蛋白潜在的非特异性结合。
尽管纯化的IgG不能完全补偿分析前因素的影响,但在高度平行的免疫分析中,IgG能够减少使用血清或血浆进行蛋白质微阵列分析时出现的非特异性效应。血液样本分析前处理导致的可重复性问题可能解释了各种生物标志物研究中报告的不一致结果。